This chapter discusses the small number of PTPs that have been identified as essential modulators of angiogenesis, offering an opportunity to discover novel therapeutic targets for obstructing angiogenesis, mainly in the context of developing tumor vasculature [230]. This evidence concerns the gene PTS and neoplasm.